BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24072069)

  • 1. Meta-analysis of serum non-ceruloplasmin copper in Alzheimer's disease.
    Squitti R; Simonelli I; Ventriglia M; Siotto M; Pasqualetti P; Rembach A; Doecke J; Bush AI
    J Alzheimers Dis; 2014; 38(4):809-22. PubMed ID: 24072069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurements of serum non-ceruloplasmin copper by a direct fluorescent method specific to Cu(II).
    Squitti R; Siotto M; Cassetta E; El Idrissi IG; Colabufo NA
    Clin Chem Lab Med; 2017 Aug; 55(9):1360-1367. PubMed ID: 28076308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copper in Alzheimer's disease: a meta-analysis of serum,plasma, and cerebrospinal fluid studies.
    Bucossi S; Ventriglia M; Panetta V; Salustri C; Pasqualetti P; Mariani S; Siotto M; Rossini PM; Squitti R
    J Alzheimers Dis; 2011; 24(1):175-85. PubMed ID: 21187586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of serum nonceruloplasmin copper for prediction of mild cognitive impairment conversion to Alzheimer disease.
    Squitti R; Ghidoni R; Siotto M; Ventriglia M; Benussi L; Paterlini A; Magri M; Binetti G; Cassetta E; Caprara D; Vernieri F; Rossini PM; Pasqualetti P
    Ann Neurol; 2014 Apr; 75(4):574-80. PubMed ID: 24623259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper subtype of Alzheimer's disease (AD): meta-analyses, genetic studies and predictive value of non-ceruloplasmim copper in mild cognitive impairment conversion to full AD.
    Squitti R
    J Trace Elem Med Biol; 2014 Oct; 28(4):482-5. PubMed ID: 25066791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with Increased Non-Ceruloplasmin Copper Appear a Distinct Sub-Group of Alzheimer's Disease: A Neuroimaging Study.
    Squitti R; Simonelli I; Cassetta E; Lupoi D; Rongioletti M; Ventriglia M; Siotto M
    Curr Alzheimer Res; 2017; 14(12):1318-1326. PubMed ID: 28669331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excess of serum copper not related to ceruloplasmin in Alzheimer disease.
    Squitti R; Pasqualetti P; Dal Forno G; Moffa F; Cassetta E; Lupoi D; Vernieri F; Rossi L; Baldassini M; Rossini PM
    Neurology; 2005 Mar; 64(6):1040-6. PubMed ID: 15781823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper dyshomeostasis in Wilson disease and Alzheimer's disease as shown by serum and urine copper indicators.
    Squitti R; Ghidoni R; Simonelli I; Ivanova ID; Colabufo NA; Zuin M; Benussi L; Binetti G; Cassetta E; Rongioletti M; Siotto M
    J Trace Elem Med Biol; 2018 Jan; 45():181-188. PubMed ID: 29173477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceruloplasmin, an indicator of copper status.
    Arredondo M; González M; Olivares M; Pizarro F; Araya M
    Biol Trace Elem Res; 2008; 123(1-3):261-9. PubMed ID: 18270661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal analysis of serum copper and ceruloplasmin in Alzheimer's disease.
    Rembach A; Doecke JD; Roberts BR; Watt AD; Faux NG; Volitakis I; Pertile KK; Rumble RL; Trounson BO; Fowler CJ; Wilson W; Ellis KA; Martins RN; Rowe CC; Villemagne VL; Ames D; Masters CL; AIBL research group ; Bush AI
    J Alzheimers Dis; 2013; 34(1):171-82. PubMed ID: 23168449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Ceruloplasmin Copper Distincts Subtypes in Alzheimer's Disease: a Genetic Study of ATP7B Frequency.
    Squitti R; Ventriglia M; Gennarelli M; Colabufo NA; El Idrissi IG; Bucossi S; Mariani S; Rongioletti M; Zanetti O; Congiu C; Rossini PM; Bonvicini C
    Mol Neurobiol; 2017 Jan; 54(1):671-681. PubMed ID: 26758278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum copper and ceruloplasmin levels in Alzheimer's disease.
    Park JH; Lee DW; Park KS
    Asia Pac Psychiatry; 2014 Mar; 6(1):38-45. PubMed ID: 23857910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Serum Ceruloplasmin Specific Activity and Risk of Alzheimer's Disease.
    Siotto M; Simonelli I; Pasqualetti P; Mariani S; Caprara D; Bucossi S; Ventriglia M; Molinario R; Antenucci M; Rongioletti M; Rossini PM; Squitti R
    J Alzheimers Dis; 2016; 50(4):1181-9. PubMed ID: 26836154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Features of ceruloplasmin in the cerebrospinal fluid of Alzheimer's disease patients.
    Capo CR; Arciello M; Squitti R; Cassetta E; Rossini PM; Calabrese L; Rossi L
    Biometals; 2008 Jun; 21(3):367-72. PubMed ID: 18060472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copper Imbalance in Alzheimer's Disease: Meta-Analysis of Serum, Plasma, and Brain Specimens, and Replication Study Evaluating
    Squitti R; Ventriglia M; Simonelli I; Bonvicini C; Costa A; Perini G; Binetti G; Benussi L; Ghidoni R; Koch G; Borroni B; Albanese A; Sensi SL; Rongioletti M
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metal-score as a potential non-invasive diagnostic test for Alzheimer's disease.
    Squitti R; Pasqualetti P; Polimanti R; Salustri C; Moffa F; Cassetta E; Lupoi D; Ventriglia M; Cortesi M; Siotto M; Vernieri F; Rossini PM
    Curr Alzheimer Res; 2013 Feb; 10(2):191-8. PubMed ID: 23036026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of copper, ceruloplasmin, and metallothionein plasma determinations in human neurodegenerative patients and their first-degree relatives.
    Arnal N; Cristalli DO; de Alaniz MJ; Marra CA
    Brain Res; 2010 Mar; 1319():118-30. PubMed ID: 20026314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Ceruloplasmin Copper Identifies a Subtype of Alzheimer's Disease (CuAD): Characterization of the Cognitive Profile and Case of a CuAD Patient Carrying an
    Squitti R; Catalli C; Gigante L; Marianetti M; Rosari M; Mariani S; Bucossi S; Mastromoro G; Ventriglia M; Simonelli I; Tondolo V; Singh P; Kumar A; Pal A; Rongioletti M
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copper in Alzheimer's disease: a meta-analysis of serum, plasma, and cerebrospinal fluid studies.
    Ventriglia M; Bucossi S; Panetta V; Squitti R
    J Alzheimers Dis; 2012; 30(4):981-4. PubMed ID: 22475798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceruloplasmin fragmentation is implicated in 'free' copper deregulation of Alzheimer's disease.
    Squitti R; Quattrocchi CC; Salustri C; Rossini PM
    Prion; 2008; 2(1):23-7. PubMed ID: 19164917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.